MRNA [NASD]
Moderna, Inc.
IndexS&P 500 P/E4.22 EPS (ttm)34.01 Insider Own5.20% Shs Outstand402.00M Perf Week10.15%
Market Cap53.83B Forward P/E16.47 EPS next Y8.70 Insider Trans-6.23% Shs Float360.23M Perf Month-4.49%
Income14.64B PEG0.25 EPS next Q4.75 Inst Own64.10% Short Float4.28% Perf Quarter-2.04%
Sales22.60B P/S2.38 EPS this Y1423.00% Inst Trans1.09% Short Ratio2.15 Perf Half Y-40.81%
Book/sh42.48 P/B3.38 EPS next Y-68.64% ROA65.50% Target Price230.27 Perf Year-13.61%
Cash/sh26.94 P/C5.32 EPS next 5Y16.80% ROE121.90% 52W Range119.01 - 497.49 Perf YTD-43.55%
Dividend- P/FCF4.13 EPS past 5Y111.10% ROI81.90% 52W High-71.18% Beta1.70
Dividend %- Quick Ratio1.60 Sales past 5Y179.40% Gross Margin84.80% 52W Low20.48% ATR10.70
Employees2700 Current Ratio1.80 Sales Q/Q213.20% Oper. Margin71.90% RSI (14)49.72 Volatility6.02% 8.00%
OptionableYes Debt/Eq0.05 EPS Q/Q202.30% Profit Margin64.80% Rel Volume1.07 Prev Close137.71
ShortableYes LT Debt/Eq0.04 EarningsMay 04 BMO Payout0.00% Avg Volume7.17M Price143.38
Recom2.60 SMA202.55% SMA50-7.10% SMA200-43.70% Volume7,689,390 Change4.12%
Feb-01-22Upgrade Redburn Sell → Neutral
Jan-26-22Upgrade Deutsche Bank Sell → Hold $175
Jan-21-22Upgrade BofA Securities Underperform → Neutral $135 → $180
Jan-21-22Initiated UBS Neutral $221
Dec-07-21Initiated Cowen Market Perform
Nov-09-21Initiated Wolfe Research Outperform $304
Oct-22-21Initiated Deutsche Bank Sell $250
Oct-15-21Upgrade Piper Sandler Neutral → Overweight $445
Aug-06-21Downgrade Piper Sandler Overweight → Neutral $246 → $445
Aug-06-21Downgrade Oppenheimer Outperform → Perform
Jul-15-21Reiterated Jefferies Hold $170 → $250
Feb-01-21Downgrade BofA Securities Neutral → Underperform
Dec-16-20Downgrade Morgan Stanley Overweight → Equal-Weight $150
Dec-16-20Downgrade Jefferies Buy → Hold $90 → $150
Dec-09-20Downgrade Needham Buy → Hold
Nov-23-20Initiated Wells Fargo Equal Weight $92
Nov-17-20Downgrade BMO Capital Markets Outperform → Market Perform $109
Sep-08-20Downgrade SVB Leerink Mkt Perform → Underperform $58 → $41
Jul-23-20Initiated SVB Leerink Mkt Perform
Jul-20-20Downgrade JP Morgan Overweight → Neutral $89
May-19-22 03:32PM  
02:16PM  
10:53AM  
May-18-22 03:55PM  
02:05PM  
11:53AM  
11:07AM  
10:10AM  
10:07AM  
09:06AM  
08:38AM  
07:52AM  
07:00AM  
12:00AM  
May-17-22 04:01PM  
10:55AM  
07:00AM  
May-16-22 04:35PM  
06:45AM  
06:41AM  
May-14-22 06:00AM  
May-13-22 05:00PM  
03:47PM  
11:45AM  
11:07AM  
10:05AM  
May-12-22 05:17PM  
03:15PM  
11:57AM  
10:43AM  
08:34AM  
May-11-22 03:50PM  
03:48PM  
03:42PM  
01:49PM  
01:06PM  
12:48PM  
10:22AM  
09:21AM  
08:43AM  
08:24AM  
08:22AM  
08:15AM  
08:00AM  
07:30AM  
06:30AM  
May-10-22 02:47PM  
May-09-22 01:51PM  
08:16AM  
07:00AM  
06:00AM  
May-08-22 08:30AM  
06:00AM  
May-07-22 07:57AM  
May-06-22 05:07PM  
02:45PM  
06:56AM  
06:39AM  
06:00AM  
05:55AM  
May-05-22 04:53PM  
10:04AM  
07:36AM  
06:46AM  
06:00AM  
May-04-22 05:08PM  
04:39PM  
04:11PM  
03:56PM  
03:25PM  
02:26PM  
01:33PM  
12:29PM  
12:26PM  
12:02PM  
11:42AM  
11:39AM  
11:02AM  
10:52AM  
10:41AM  
10:11AM  
09:48AM  
09:12AM  
08:56AM  
08:25AM  
07:48AM  
07:33AM  
07:09AM  
07:04AM  
07:02AM  
06:52AM  
03:45AM  
May-03-22 12:08PM  
May-02-22 04:24PM  
03:44PM  
03:21PM  
01:22PM  
10:26AM  
09:48AM  
06:22AM  
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, Metagenomi, Inc., and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd.; Catalent Inc., Laboratorios Farmaceuticos Rovi, S.A., Recipharm, and Lonza Group; Aldevron, LLC; Institute for Life Changing Medicines; and AbCellera Biologics Inc. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hoge StephenPresidentMay 13Option Exercise4.2915,00064,4001,637,820May 16 04:09 PM
AFEYAN NOUBARDirectorMay 13Sale134.47100,00013,446,6115,816,657May 13 07:30 PM
Hoge StephenPresidentMay 13Sale132.6915,0001,990,3501,622,820May 16 04:09 PM
Hoge StephenPresidentMay 12Option Exercise10.905,00054,5001,627,820May 16 04:09 PM
Bancel StephaneChief Executive OfficerMay 12Sale121.1010,0001,211,0006,894,880May 13 04:42 PM
AFEYAN NOUBARDirectorMay 12Sale130.51200,00026,101,1755,916,657May 13 07:30 PM
Hoge StephenPresidentMay 12Sale121.105,000605,5001,622,820May 16 04:09 PM
Bancel StephaneChief Executive OfficerMay 11Sale127.139,0001,144,1645,395,535May 13 04:42 PM
AFEYAN NOUBARDirectorMay 11Sale130.7410,0001,307,4002,229,673May 13 07:30 PM
Nader FrancoisDirectorMay 10Option Exercise18.8723,100435,89723,803May 12 04:22 PM
Andres JuanSee remarksMay 10Sale133.7119526,0749,309May 11 04:24 PM
Meline David WChief Financial OfficerMay 10Sale133.7115620,8592,583May 11 04:26 PM
Hoge StephenPresidentMay 10Sale133.7123431,2891,622,820May 11 04:29 PM
Nader FrancoisDirectorMay 10Sale136.103,196434,97620,607May 12 04:22 PM
Andres JuanSee remarksMay 09Option Exercise134.4043558,4649,504May 11 04:24 PM
Meline David WChief Financial OfficerMay 09Option Exercise134.4034846,7712,739May 11 04:26 PM
Hoge StephenPresidentMay 09Option Exercise134.4052270,1571,623,054May 11 04:29 PM
Bancel StephaneChief Executive OfficerMay 05Sale151.8710,0001,518,7006,904,880May 06 04:09 PM
Andres JuanSee remarksMay 04Option Exercise14.222,00028,44011,069May 06 04:06 PM
Andres JuanSee remarksMay 04Sale153.232,000306,4609,069May 06 04:06 PM
Bancel StephaneChief Executive OfficerMay 04Sale147.259,0001,325,2725,408,535May 06 04:09 PM
Hoge StephenPresidentMay 03Option Exercise0.9910,0009,9001,632,532May 04 04:37 PM
Hoge StephenPresidentMay 03Sale141.9310,0001,419,3001,622,532May 04 04:37 PM
Hoge StephenPresidentMay 02Option Exercise0.9910,0009,9001,632,532May 04 04:37 PM
Hoge StephenPresidentMay 02Sale134.8710,0001,348,7001,622,532May 04 04:37 PM
Andres JuanSee remarksApr 29Option Exercise14.222,00028,44011,069May 02 04:24 PM
Andres JuanSee remarksApr 29Sale150.002,000300,0009,069May 02 04:24 PM
AFEYAN NOUBARDirectorApr 28Option Exercise0.0070302,239,673May 02 08:24 PM
NABEL ELIZABETH GDirectorApr 28Option Exercise0.007030703May 02 04:37 PM
Horning SandraDirectorApr 28Option Exercise0.007030703May 02 04:38 PM
Tallett Elizabeth EDirectorApr 28Option Exercise0.007030703May 02 04:39 PM
Nader FrancoisDirectorApr 28Option Exercise0.007030703May 02 04:40 PM
SAGAN PAULDirectorApr 28Option Exercise0.007030703May 02 04:42 PM
LANGER ROBERTDirectorApr 28Option Exercise0.00703011,467,664May 02 04:45 PM
Berenson StephenDirectorApr 28Option Exercise0.00703020,801May 02 04:47 PM
Bancel StephaneChief Executive OfficerApr 28Sale143.7310,0001,437,3006,914,880Apr 29 04:18 PM
Bancel StephaneChief Executive OfficerApr 27Sale142.149,0001,279,3015,421,535Apr 29 04:18 PM
Hoge StephenPresidentApr 25Option Exercise5.9520,000118,9001,642,532Apr 26 04:07 PM
Hoge StephenPresidentApr 25Sale143.2220,0002,864,4971,622,532Apr 26 04:07 PM
Bancel StephaneChief Executive OfficerApr 21Sale149.4310,0001,494,3006,924,880Apr 22 04:05 PM
Andres JuanSee remarksApr 20Option Exercise14.222,00028,44011,069Apr 22 04:08 PM
Andres JuanSee remarksApr 20Sale153.002,000306,0009,069Apr 22 04:08 PM
Bancel StephaneChief Executive OfficerApr 20Sale150.599,0001,355,2815,434,535Apr 22 04:05 PM
Bancel StephaneChief Executive OfficerApr 14Sale168.5910,0001,685,9006,934,880Apr 15 03:16 PM
Andres JuanSee remarksApr 13Option Exercise14.222,00028,44011,069Apr 15 03:09 PM
Hoge StephenPresidentApr 13Option Exercise4.2915,00064,4001,637,532Apr 14 04:06 PM
Bancel StephaneChief Executive OfficerApr 13Sale170.269,0001,532,3475,443,535Apr 15 03:16 PM
Andres JuanSee remarksApr 13Sale158.372,000316,7409,069Apr 15 03:09 PM
Hoge StephenPresidentApr 13Sale158.3715,0002,375,5501,622,532Apr 14 04:06 PM
Hoge StephenPresidentApr 12Option Exercise10.905,00054,5001,627,532Apr 14 04:06 PM
Hoge StephenPresidentApr 12Sale159.005,000795,0001,622,532Apr 14 04:06 PM
Bancel StephaneChief Executive OfficerApr 07Sale153.1510,0001,531,5006,944,880Apr 08 04:03 PM
Andres JuanSee remarksApr 06Option Exercise14.222,00028,44011,069Apr 08 04:06 PM
Andres JuanSee remarksApr 06Sale157.502,000315,0009,069Apr 08 04:06 PM
Bancel StephaneChief Executive OfficerApr 06Sale158.709,0001,428,2925,460,535Apr 08 04:03 PM
Hoge StephenPresidentApr 04Option Exercise0.9920,00019,8001,642,532Apr 05 04:11 PM
Hoge StephenPresidentApr 04Sale177.2720,0003,545,4001,622,532Apr 05 04:11 PM
Bancel StephaneChief Executive OfficerMar 31Sale175.2210,0001,752,2006,954,880Apr 01 04:04 PM
Andres JuanSee remarksMar 30Option Exercise14.222,00028,44011,069Apr 01 04:06 PM
Bancel StephaneChief Executive OfficerMar 30Sale176.839,0001,591,4455,473,535Apr 01 04:04 PM
Andres JuanSee remarksMar 30Sale182.792,000365,5809,069Apr 01 04:06 PM
Hoge StephenPresidentMar 24Option Exercise10.905,00054,5001,627,532Mar 25 04:09 PM
Bancel StephaneChief Executive OfficerMar 24Sale175.5210,0001,755,2006,964,880Mar 25 04:07 PM
Hoge StephenPresidentMar 24Sale175.525,000877,6001,622,532Mar 25 04:09 PM
Andres JuanSee remarksMar 23Option Exercise14.222,00028,44011,069Mar 25 04:13 PM
Hoge StephenPresidentMar 23Option Exercise4.2915,00064,4001,637,532Mar 25 04:09 PM
Hoge StephenPresidentMar 23Sale181.8115,0002,727,0791,622,532Mar 25 04:09 PM
Bancel StephaneChief Executive OfficerMar 23Sale180.159,0001,621,3395,486,535Mar 25 04:07 PM
Andres JuanSee remarksMar 23Sale184.662,000369,3209,069Mar 25 04:13 PM
Hoge StephenPresidentMar 18Sale171.677,5411,294,5331,622,532Mar 21 06:07 PM
Hoge StephenPresidentMar 17Option Exercise151.3319,2822,917,9451,630,073Mar 21 06:07 PM
Bancel StephaneChief Executive OfficerMar 17Sale168.0010,0001,680,0006,974,880Mar 18 04:07 PM
Andres JuanSee remarksMar 16Option Exercise14.222,00028,44011,069Mar 18 04:09 PM
Bancel StephaneChief Executive OfficerMar 16Sale161.639,0001,454,6885,499,535Mar 18 04:07 PM
Andres JuanSee remarksMar 16Sale150.012,000300,0209,069Mar 18 04:09 PM
Andres JuanSee remarksMar 14Option Exercise14.222,00028,44011,069Mar 15 04:19 PM
Hoge StephenPresidentMar 14Option Exercise5.9520,000118,9001,630,791Mar 15 04:22 PM
Andres JuanSee remarksMar 14Sale150.002,000300,0009,069Mar 15 04:19 PM
Hoge StephenPresidentMar 14Sale140.2620,0002,805,2001,610,791Mar 15 04:22 PM
Bancel StephaneChief Executive OfficerMar 10Sale139.5410,0001,395,4006,984,880Mar 11 04:09 PM
Bancel StephaneChief Executive OfficerMar 09Sale132.059,0001,188,4505,512,535Mar 11 04:09 PM
Hoge StephenPresidentMar 03Option Exercise0.9910,0009,9001,620,791Mar 04 04:15 PM
Hoge StephenPresidentMar 03Sale147.9010,0001,479,0001,610,791Mar 04 04:15 PM
Bancel StephaneChief Executive OfficerMar 03Sale147.9010,0001,479,0006,994,880Mar 04 04:13 PM
Hoge StephenPresidentMar 02Option Exercise0.9910,0009,9001,620,791Mar 03 04:56 PM
Andres JuanSee remarksMar 02Option Exercise14.222,00028,44011,069Mar 03 04:53 PM
Hoge StephenPresidentMar 02Sale149.4410,0001,494,4001,610,791Mar 03 04:56 PM
Bancel StephaneChief Executive OfficerMar 02Sale149.449,0001,344,9605,525,535Mar 03 04:49 PM
Andres JuanSee remarksMar 02Sale150.002,000300,0009,069Mar 03 04:53 PM
Andres JuanSee remarksMar 01Sale152.536,365970,8229,069Mar 02 04:27 PM
Andres JuanSee remarksFeb 28Option Exercise0.0014,462015,434Mar 02 04:27 PM
Andres JuanSee remarksFeb 24Option Exercise14.222,00028,4402,972Feb 25 04:35 PM
Andres JuanSee remarksFeb 24Sale150.002,000300,000972Feb 25 04:35 PM
Bancel StephaneChief Executive OfficerFeb 24Sale139.8010,0001,398,0007,004,880Feb 25 04:43 PM
Bancel StephaneChief Executive OfficerFeb 23Sale144.609,0001,301,4005,688,535Feb 25 04:43 PM
Bancel StephaneChief Executive OfficerFeb 17Sale150.4910,0001,504,9007,014,880Feb 18 04:32 PM
Andres JuanSee remarksFeb 16Option Exercise14.222,00028,4402,972Feb 18 04:34 PM
Andres JuanSee remarksFeb 16Sale150.002,000300,000972Feb 18 04:34 PM
Bancel StephaneChief Executive OfficerFeb 16Sale147.809,0001,330,2005,701,535Feb 18 04:32 PM
Hoge StephenPresidentFeb 14Option Exercise5.9520,000118,9001,630,791Feb 15 04:35 PM